Retatrutide is an experimental triple-hormone-receptor-agonist injection that activates GLP-1, GIP, and glucagon receptors to provide unprecedented weight loss and metabolic improvements
Key takeaways
Retatrutide’s benefits include weight loss, blood glucose (sugar) reduction, reduced cardiovascular risk factors, and osteoarthritis pain relief.
Profound Weight Loss: Clinical trials show average body weight reductions of 24% to 28% at higher doses.
Blood Sugar Control: Lowers hemoglobin A1C by roughly 1.7% to 2% in adults with Type 2 diabetes.
Cardiovascular & Metabolic Health: Lowers systolic blood pressure, improves cholesterol panels, and decreases systemic inflammation markers.
Joint Pain Relief: Demonstrates significant knee pain reduction and improved physical function in individuals with knee osteoarthritis and obesity.
Liver Fat Reduction: Early sub-studies show a dramatic reduction of liver fat in patients with fatty liver disease.
Common Side Effects
Common Side Effects it works similarly to other incretin-based therapies like Wegovy or Mounjaro, retatrutide's most frequently reported adverse events are gastrointestinal and tend to be dose-dependent.
For research and educational purposes only.
